Krishna Institute of Medical Sciences Limited Stock Price Today (NSE: KIMS)
Fundamental Score
Krishna Institute of Medical Sciences Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Krishna Institute of Medical Sciences Limited share price today is ₹758.40, up +0.38% on NSE/BSE as of 1 September 2026. Krishna Institute of Medical Sciences Limited (KIMS) is a Large-cap company in the Hospital sector with a market capitalisation of ₹33.95K (Cr). The 52-week high for KIMS share price is ₹858.00 and the 52-week low is ₹575.80. At a P/E ratio of 166.00x, KIMS is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 11.01% and a debt-to-equity ratio of 1.44.
Krishna Institute of Medical Sciences Limited Share Price Chart — NSE/BSE Historical Performance
Krishna Institute of Medical Sciences Limited share price chart: 2.14% return over the past month. 52-week high ₹858.00, 52-week low ₹575.80.
Krishna Institute of Medical Sciences Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹770.00 | ₹783.40 | ₹765.50 | ₹772.50 | 11.19L (Cr) | |
| ₹800.00 | ₹808.90 | ₹800.00 | ₹805.50 | 2.18L (Cr) | |
| ₹809.90 | ₹827.95 | ₹804.10 | ₹809.10 | 4.14L (Cr) | |
| ₹800.00 | ₹811.00 | ₹799.10 | ₹807.55 | 2.68L (Cr) | |
| ₹810.50 | ₹814.55 | ₹800.00 | ₹803.95 | 4.60L (Cr) | |
| ₹819.00 | ₹819.50 | ₹806.10 | ₹813.05 | 8.52L (Cr) | |
| ₹811.15 | ₹822.50 | ₹804.10 | ₹819.50 | 4.42L (Cr) | |
| ₹803.10 | ₹826.80 | ₹803.10 | ₹811.10 | 18.02L (Cr) | |
| ₹803.00 | ₹819.80 | ₹801.00 | ₹808.60 | 5.04L (Cr) | |
| ₹795.90 | ₹815.00 | ₹783.15 | ₹802.15 | 6.56L (Cr) |
Krishna Institute of Medical Sciences Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹805.95 | ₹827.95 | ₹765.50 | ₹772.50 | -4.15% | |
| ₹818.00 | ₹858.00 | ₹779.05 | ₹804.70 | -1.63% | |
| ₹759.50 | ₹834.70 | ₹725.40 | ₹814.60 | +7.25% | |
| ₹672.00 | ₹791.15 | ₹663.00 | ₹758.85 | +12.92% | |
| ₹630.10 | ₹691.90 | ₹613.00 | ₹666.70 | +5.81% | |
| ₹712.35 | ₹735.00 | ₹610.80 | ₹621.50 | -12.75% | |
| ₹593.00 | ₹757.50 | ₹578.60 | ₹745.05 | +25.64% | |
| ₹610.50 | ₹667.15 | ₹575.80 | ₹603.75 | -1.11% | |
| ₹690.25 | ₹712.00 | ₹599.85 | ₹608.60 | -11.83% | |
| ₹724.50 | ₹733.45 | ₹653.65 | ₹685.10 | -5.44% | |
| ₹700.15 | ₹742.80 | ₹676.80 | ₹721.05 | +2.99% | |
| ₹721.50 | ₹772.00 | ₹697.30 | ₹700.15 | -2.96% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Krishna Institute of Medical Sciences Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Krishna Institute of Medical Sciences Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KIMS across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (27.04%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Revenue Growth (35.33%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (24.04% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Institutional Confidence (FII+DII: 47.07%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
10 factors identified
Suboptimal ROCE (9.35%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 166.00x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Price-to-Book Ratio (15.11x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Profit Decline Concern (-47.20%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-25.83% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (3.71% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Elevated Debt Levels (D/E: 1.44)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Liquidity Concerns (Current Ratio: 0.76)
Observation: Current assets may not adequately cover short-term liabilities.
Analysis: Current ratio <1.0 raises working capital concerns.
Negative Free Cash Flow (₹-1459.04 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Krishna Institute of Medical Sciences Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Krishna Institute of Medical Sciences Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
13.9/100 | ₹758.40₹758 | ₹33947.05₹33947.05 | 166.00Average 166.0 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 62.1/100 | ₹8817.00₹8817 | ₹128448.55₹128448.55 | 61.47Average 61.5 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 56.9/100 | ₹1014.40₹1014 | ₹107422.79₹107422.79 | 73.71Average 73.7 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | — — | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 56.8/100 | ₹916.70₹917 | ₹73687.64₹73687.64 | 70.32Average 70.3 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | — — | 17.76%Excellent 17.76% Excellent | 0.10% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 37.2/100 | ₹818.00₹818 | ₹71917.90₹71917.90 | 225.67Average 225.7 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 68.3/100 | ₹1803.00₹1803 | ₹41592.95₹41592.95 | 50.96Average 51.0 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | — — | 25.05%Excellent 25.05% Excellent | 0.22% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 59.9/100 | ₹1442.70₹1443 | ₹35993.93₹35993.93 | 64.72Average 64.7 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | — — | — — | 0.04% |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 48.5/100 | ₹502.60₹503 | ₹15618.15₹15618.15 | 105.26Average 105.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | — — | — — | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 65.5/100 | ₹1458.70₹1459 | ₹15270.28₹15270.28 | 53.51Average 53.5 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | — — | — — | 0.23% |
60/100 | ₹318.20₹318 | ₹9829.95₹9829.95 | 52.28Average 52.3 Average | 13.41%Average 13.41% Average | 15.25%Good 15.25% Good | 0.33Excellent 0.3 Excellent | — — | — — | 0.07% | |
42.7/100 | ₹713.65₹714 | ₹9663.25₹9663.25 | 424.20Average 424.2 Average | 1.22%Poor 1.22% Poor | 7.43%Poor 7.43% Poor | 0.68Good 0.7 Good | — — | 20.22%Excellent 20.22% Excellent | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price128448.55 Cr
- Max Healthcare Institute Limited share price107422.79 Cr
- Fortis Healthcare Limited share price73687.64 Cr
- Aster DM Quality Care Limited share price71917.90 Cr
- Narayana Hrudayalaya Ltd. share price41592.95 Cr
Krishna Institute of Medical Sciences Limited PE Ratio History
Historical price-to-earnings ratio for KIMS — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹9.61 | ₹608.60 | 63.3x |
| FY 2024 | ₹7.75 | ₹598.00 | 77.2x |
| FY 2023 | ₹8.41 | ₹1979.20 | 235.5x |
| FY 2022 | ₹8.38 | ₹1547.30 | 184.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Krishna Institute of Medical Sciences Limited Quarterly Performance
Latest quarterly metrics for KIMS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
35.33%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-47.20%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
24.04%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
3.71%
Compounded annual net profit growth over 5 years
Krishna Institute of Medical Sciences Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for KIMS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Krishna Institute of Medical Sciences Limited Financial Statements
Annual income statement, balance sheet and cash flow for Krishna Institute of Medical Sciences Limited (KIMS) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Krishna Institute of Medical Sciences Limited
About KIMS (Krishna Institute of Medical Sciences Limited)
Krishna Institute of Medical Sciences Ltd is a beacon of hope and healing, a multi-specialty hospital group renowned for its advanced medical infrastructure and compassionate patie...nt care. Towering structures house state-of-the-art operating theaters equipped with robotic surgical systems, cutting-edge diagnostic imaging centers, and specialized intensive care units designed to meet the diverse needs of critically ill patients. Stepping inside, one is immediately enveloped in an atmosphere of clinical precision blended with human empathy, as highly trained medical professionals collaborate seamlessly to deliver personalized treatment plans. The hospital's corridors resonate with the quiet hum of sophisticated medical equipment, a testament to its commitment to embracing technological advancements for improved patient outcomes. Each ward is meticulously maintained, offering a sanctuary of comfort and tranquility for those on their journey to recovery. Within KIMS, a constellation of medical specialties thrives, each department a center of excellence dedicated to pushing the boundaries of medical knowledge. Neurological disorders find sophisticated diagnosis and treatment within specialized units, supported by advanced neuro-imaging and rehabilitation programs. The heart center pulsates with innovation, offering a comprehensive range of cardiac services from minimally invasive procedures to complex heart transplants. Respiratory ailments are addressed with cutting-edge interventions, including advanced diagnostics, interventional pulmonology, and lung transplantation. The digestive health institute stands as a leader in gastrointestinal care, performing intricate surgeries and offering advanced treatments for liver and pancreatic diseases. KIMS embraces holistic healthcare, incorporating preventative medicine, wellness programs, and patient education to empower individuals to take control of their health. At the heart of KIMS lies a dedicated team of physicians, surgeons, nurses, and support staff united by a common mission: to provide exceptional healthcare with unwavering compassion. These highly skilled professionals are not only experts in their respective fields but also empathetic caregivers who understand the importance of human connection in the healing process. Every patient is treated with dignity and respect, their individual needs carefully considered in the development of a tailored treatment plan. KIMS fosters a culture of continuous learning and improvement, encouraging its staff to participate in ongoing research and training programs to stay at the forefront of medical innovation. This commitment to excellence ensures that patients receive the highest quality care, delivered with empathy and precision.
Company Details
Key Leadership
Corporate Events
Latest News
KIMS Share Price: Frequently Asked Questions
What is the current share price of Krishna Institute of Medical Sciences Limited?
Krishna Institute of Medical Sciences Limited (KIMS) trades at ₹758.40 on NSE and BSE. Market cap ₹33.95K (Cr). Educational data only.
What is the P/E ratio of Krishna Institute of Medical Sciences Limited?
Krishna Institute of Medical Sciences Limited has a P/E of 166.00x vs industry average 48.79x.
What is the Bull Run score for Krishna Institute of Medical Sciences Limited?
Krishna Institute of Medical Sciences Limited has a Bull Run score of 13.9/100 based on 25+ financial parameters.
Does Krishna Institute of Medical Sciences Limited pay dividends?
Krishna Institute of Medical Sciences Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Krishna Institute of Medical Sciences Limited?
Krishna Institute of Medical Sciences Limited has ROE of 11.01%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Krishna Institute of Medical Sciences Limited?
Krishna Institute of Medical Sciences Limited has debt-to-equity of 1.44.
Is Krishna Institute of Medical Sciences Limited a good investment?
Bull Run gives Krishna Institute of Medical Sciences Limited a score of 13.9/100. This is not investment advice — consult a SEBI-registered advisor.